Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients Full Text
Clinical Cancer Research,  Clinical Article

Griffioen AW et al. – This study describes for the first time the angiostatic response in human primary renal cancers at the tissue level upon treatment with VEGF targeted therapy. Discontinuation of treatment with tyrosine kinase inhibitors leads to accelerated angiogenesis. The results of the current study contribute important data to the ongoing discussion on the discontinuation of treatment with kinase inhibitors.

Methods
  • Phase II trials of VEGF pathway targeted therapy given prior to cytoreductive surgery were performed with metastatic RCC patients with the primary tumor in situ, to investigate the necessity of nephrectomy.
  • Primary tumor tissues were obtained and assessed for angiogenesis parameters.
  • Results were compared to similar analyses on untreated tumors.

Results
  • Sunitinib or bevacizumab pretreatment resulted in a significant reduction of microvessel density in the primary tumor.
  • Also, an increase in vascular pericyte coverage was found in sunitinib-pretreated tumors, consistent with efficient angiogenesis inhibition.
  • Expression of several key regulators of angiogenesis was suppressed in pretreated tissues, among which VEGFR-1 and -2, angiopoietin-1 and -2 and PDGF-B.
  • In addition, apoptosis in tumor and endothelial cells was induced. Interestingly, in sunitinib-pretreated tissues a dramatic increase of the number of proliferating endothelial cells was observed, which was not the case in bevacizumab-pretreated tumors.
  • A positive correlation with the interval between halting the therapy and surgery was found, suggesting a compensatory angiogenic response caused by the discontinuation of sunitinib treatment.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 Muscle mass and chronic kidney disease Yale School of Medicine News, November 13, 2014

2 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

3 Effects of tea intake on blood pressure: A meta-analysis of 21 randomized controlled trials JACC - Journal of the American College of Cardiology, October 22, 2014    Clinical Article

4 Associations of sugar and artificially sweetened soda and chronic kidney disease: A systematic review and meta-analysis Nephrology, September 26, 2014    Evidence Based Medicine    Review Article

5 Tonsillectomy for IgA nephropathy: A meta-analysis American Journal of Kidney Diseases, October 29, 2014    Evidence Based Medicine

6 Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American college of physicians Annals of Internal Medicine, November 11, 2014    Evidence Based Medicine    Clinical Article

7 Hypertension in the United States, 1999 to 2012 Circulation, November 6, 2014    Clinical Article

8 Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD Clinical Journal of the American Society of Nephrology, November 13, 2014    Clinical Article

9 Erythropoietin and resistant hypertension in CKD Seminars in Nephrology, November 25, 2014    Clinical Article

10 Sudden cardiac death in end stage renal disease: Unlocking the mystery Full Text Journal of Nephrology, November 13, 2014    Free full text    Review Article

11 The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): A prospective randomized controlled trial Critical Care, January 13, 2014    Clinical Article

12 Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis Canadian Medical Association Journal, August 12, 2013    Evidence Based Medicine    Review Article    Clinical Article

13 Drug-induced reduction in albuminuria is associated with subsequent renoprotection: A meta-analysis Journal of the American Society of Nephrology, November 26, 2014    Evidence Based Medicine    Clinical Article

14 Effects of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: A Phase IIb, randomized study Full Text BMC Nephrology, November 19, 2014    Free full text    Clinical Article

15 A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography Nephrology Dialysis Transplantation, May 5, 2014    Clinical Article

16 Maintaining safety in the dialysis facility Clinical Journal of the American Society of Nephrology, November 12, 2014    Clinical Article

17 Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD Journal of the American Society of Nephrology, November 19, 2014    Clinical Article

18 Pathophysiology and treatment of resistant hypertension: The role of aldosterone and amiloride-sensitive sodium channels Seminars in Nephrology, November 24, 2014    Review Article

19 Acute kidney injury and prognosis after cardiopulmonary bypass: A meta-analysis of cohort studies American Journal of Kidney Diseases, November 7, 2014    Evidence Based Medicine    Clinical Article
Exclusive Author Commentary

20 Role of aldosterone blockade in resistant hypertension Seminars in Nephrology, October 30, 2014    Review Article

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore